Home
>
National Drug Code (NDC)
>
Linden
Linden - 36987-2731-4 - (Linden)
Drug Information of Linden
| Product NDC: | 36987-2731 |
| Proprietary Name: | Linden |
| Non Proprietary Name: | Linden |
| Active Ingredient(s): | .05 g/mL & nbsp; Linden |
| Administration Route(s): | INTRADERMAL; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Linden
| Product NDC: | 36987-2731 |
| Labeler Name: | Nelco Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA102192 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19720829 |
Package Information of Linden
| Package NDC: | 36987-2731-4 |
| Package Description: | 50 mL in 1 VIAL, MULTI-DOSE (36987-2731-4) |
NDC Information of Linden
| NDC Code | 36987-2731-4 |
| Proprietary Name | Linden |
| Package Description | 50 mL in 1 VIAL, MULTI-DOSE (36987-2731-4) |
| Product NDC | 36987-2731 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Linden |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRADERMAL; SUBCUTANEOUS |
| Start Marketing Date | 19720829 |
| Marketing Category Name | BLA |
| Labeler Name | Nelco Laboratories, Inc. |
| Substance Name | TILIA AMERICANA POLLEN |
| Strength Number | .05 |
| Strength Unit | g/mL |
| Pharmaceutical Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
